Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

IVUS in Unprotected LMCA Angioplasty: Should We Change the Way We Use It?

Courtesy of Dr. Carlos Fava.

Bifurcation lesions account for about 25% of all angioplasties and it is a challenge for which there is no single treatment strategy.

La era del stent provisional para las bifurcaciones parece llegar a su fin

Intravascular ultrasound (IVUS) has proven its usefulness, improving outcomes by reducing mortality in unprotected left main coronary artery (LMCA) angioplasty.

A new strategy consists in conducting an IVUS after pre-dilation, after stent implantation, and post-dilation. However, such alternative has not been validated yet.

Researchers analyzed 9525 patients from the IRIS-DES registry with severe left main coronary artery, bifurcation, long or diffuse (>30 mm), or severely calcified lesions controlled through IVUS. Among them, 3374 (35.4%) patients underwent endoluminal ultrasound at pre-dilation, after stent implantation, and post-dilation (iPSP).


Read also: Detection of Late Complications After EVAR.


The primary endpoint at follow-up was cardiac death, target-vessel infarction, and target-vessel revascularization (TVR).

Patients who underwent iPSP angioplasty were younger and mostly male, had more risk factors, bifurcation lesions, severe calcification, longer lesions, and more stents. Consequently, researchers used propensity score matching to adjust populations and reach uniformity, leaving 3130 patients in each group.

The follow-up went on for 3 years and the primary endpoint favored iPSP patients (5.6% vs. 7.9%; adjusted hazard ratio [HR]: 0.71; 95% confidence interval [CI]: 0.63 to 0.81; p < 0.001).


Read also: EuroPCR 2020 | Aortic Valve in Valve in the Long Term.


Analyzing the secondary endpoints, iPSP was associated with lower mortality (2.2% vs. 3.4%; adjusted HR: 0.62; 95% CI: 0.51 to 0.75; p 0.003) and TVR (3.4% vs. 4.6%; adjusted HR: 0.74; 95% CI: 0.63 to 0.87; p < 0.001), and there were no differences as regards infarction (0.3% vs. 0.5%; adjusted HR: 0.65; 95% CI: 0.38 to 1.10; p = 0.10).

Conclusion

In patients who underwent complex unprotected left main coronary artery angioplasty with drug-eluting stents (DES), iPSP was associated with a lower risk of cardiac events after 3 years of follow-up.

Consequently, iPSP should be used more proactively in complex coronary angioplasties nowadays.

Courtesy of Dr. Carlos Fava.

Título Original: Optimal Stenting Technique for Complex Coronary Lesions Intracoronary Imaging-Guided Pre-Dilation, Stent Sizing, and Post-Dilation.

Referencia: Hanbit Park, el al. J AmColl Cardiol Intv 2020;13:1403–13.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...

Calcified Nodules and Their Treatment with Rotational Atherectomy

Calcified nodules (CN) represent one of the most complex phenotypes to treat in coronary intervention. They are mainly associated with the need for repeat...

Complex PCI: higher ischemic and bleeding risk in contemporary practice

Advances in pharmacological therapies, equipment, and devices have enabled percutaneous coronary interventions (PCI) to be performed in a growing number of patients with a...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...